Table 1:
Acute seizure | No acute seizure | Epilepsy | No epilepsy | |||||||
---|---|---|---|---|---|---|---|---|---|---|
N=9 | N=15 | N=6 | N=18 | |||||||
Demographic/Characteristic | n | (%) | n | % | P value | n | % | n | % | P-value |
Male | 5 | (56) | 11 | (73) | 0.371 | 3 | (50) | 13 | (72) | 0.317 |
Neonate | 2 | (22) | 3 | (20) | 0.897 | 1 | (17) | 4 | (22) | 0.772 |
Age at diagnosis (median y, IQR) | 0.9 | (0.1 – 3.2) | 1.7 | (0.2 – 6.1) | 0.999 | 1.0 | (0.4 – 12.8) | 1.5 | (0.1 – 4.6) | 0.640 |
CSVT risk factors | ||||||||||
Chronic medical disorder | 4 | (44) | 6 | (40) | 0.999 | 3 | (50) | 7 | (39) | 0.633 |
Acute systemic illness | 6 | (67) | 7 | (47) | 0.340 | 3 | (50) | 10 | (56) | 0.813 |
Dehydration | 4 | (44) | 3 | (33) | 0.202 | 2 | (33) | 5 | (28) | 0.795 |
Local infection* | 2 | (22) | 5 | (56) | 0.562 | 2 | (33) | 5 | (28) | 0.795 |
Acute clinical presentation | ||||||||||
Hemiparesis | 4 | (44) | 2 | (13) | 0.15 | 2 | (33) | 4 | (22) | 0.586 |
Visual field defect | 0 | 1 | (7) | 0.999 | 0 | 0 | 0.999 | |||
Decreased LOC | 2 | (22) | 4 | (27) | 0.999 | 1 | (17) | 5 | (28) | 0.586 |
Headache | 2 | (22) | 7 | (47) | 0.389 | 2 | (33) | 7 | (39) | 0.808 |
Papilledema | 1 | (11) | 2 | (13) | 0.999 | 0 | 3 | (17) | 0.546 | |
Imaging Findings (N = 22) | N=9 | N=13 | N=6 | N=16 | ||||||
Ischemic infarct | 2 | (25) | 3 | (23) | 0.999 | 1 | (17) | 8 | (50) | 0.157 |
Multiple infarcts | 0 | 3 | (23) | 0.257 | 1 | (17) | 2 | (13) | 0.800 | |
Subcortical infarcts only | 0 | 2 | (15) | 0.505 | 0 | 2 | (13) | 0.999 | ||
Hemorrhage | 3 | (38) | 1 | (8) | 0.253 | 2 | (17) | 2 | (13) | 0.259 |
Meningitis, sinusitis, otitis media or mastoiditis